Market Overview The US antifungal treatment market is advancing as dermatophyte infections drive topical and oral antifungal demand across American dermatology and primary care practices. The US Antifungal Treatment Market is projected to grow through 2030, driven by increasing onychomycosis prevalence in aging population, growing athlete's foot and ringworm in active populations, rising tinea...